```html

Knuckle Pads – A Complete Medical Guide

Overview

Knuckle pads are localized, thickened, firm, raised lesions that develop over the dorsal (back) surface of the interphalangeal joints, most commonly the proximal interphalangeal (PIP) and distal interphalangeal (DIP) joints. They are a form of benign fibromatosis, meaning they consist of excess fibrous tissue rather than cancerous growth.

These lesions are usually painless, but they can become uncomfortable or limit finger motion when they enlarge. Knuckle pads may appear as solitary nodules or in clusters, and they often have a smooth, dome‑shaped appearance that can be skin‑colored, pink, or slightly hyperpigmented.

Who It Affects

• Age: Most cases arise in late adolescence or early adulthood (15‑35 years), though they can appear at any age.
• Gender: Slight male predominance (≈ 60 % male) has been reported in several case series.
• Population: Occurs worldwide; exact prevalence is unknown because many individuals never seek medical care. Estimates suggest < 1 % of dermatology clinic patients present with knuckle pads.

Symptoms

Knuckle pads are usually asymptomatic, but a range of signs may be present:

• Firm, raised nodules (2 mm–1 cm) over the dorsal aspect of one or more finger joints.
• Skin‑colored to pink or brown hue.
• Well‑defined borders that feel rubbery or fibrous on palpation.
• Non‑painful in most cases; occasional tenderness if the pad is traumatized.
• Limited joint flexion when the pad becomes large enough to interfere with finger movement.
• Cosmetic concern – many patients seek care because the pads are visible.
• Associated skin conditions – knuckle pads can coexist with other fibromatoses such as Dupuytren’s contracture, plantar fibromatosis (Ledderhose disease), or palmoplantar keratoderma.

Causes and Risk Factors

The exact cause of knuckle pads remains uncertain, but several mechanisms have been proposed:

1. Primary (Idiopathic) Fibromatosis

In many people, knuckle pads appear without any identifiable trigger, suggesting a genetic predisposition to fibroblast proliferation. Familial cases have been reported, hinting at autosomal‑dominant inheritance with variable penetrance.

2. Repetitive Trauma or Friction

Repeated mechanical stress—such as martial arts, weight‑lifting, playing stringed instruments, or manual labor—can stimulate fibroblast activity, leading to localized thickening. This form is sometimes called “traumatic knuckle pads.”

3. Associated Dermatologic Syndromes

Knuckle pads are part of the “fibromatosis spectrum” and may coexist with:

• Dupuytren’s contracture (palmar fibromatosis)
• Plantarfibromatosis (Ledderhose disease)
• Epidermolysis bullosa, especially the “knuckle‑pad” variant

Risk Factors

• Male sex
• Age 15‑35 years (peak incidence)
• Family history of fibromatoses
• Occupations or hobbies that involve chronic pressure on the finger joints (e.g., carpenters, musicians, athletes)
• Co‑existing Dupuytren’s contracture or plantar fibromatosis

Diagnosis

Diagnosis is primarily clinical, based on appearance and palpation. A thorough history helps differentiate knuckle pads from other conditions such as warts, cysts, or malignant tumors.

Clinical Evaluation

• History: Onset, progression, occupational or recreational activities, family history of fibromatosis.
• Physical exam: Firm, non‑compressible nodules with well‑defined margins; absence of ulceration or rapid growth.

Diagnostic Tests (when needed)

• Dermatoscopy: Shows homogenous, white‑to‑yellow areas without vascular patterns, helping rule out viral warts.
• Skin biopsy: Rarely required; histology reveals thickened collagen bundles, increased fibroblasts, and sometimes elastin degeneration.
• Imaging: Ultrasound or MRI can assess depth and rule out underlying joint pathology if the diagnosis is unclear.
• Laboratory work: Generally not indicated unless a systemic fibromatosis syndrome is suspected.

Treatment Options

Because knuckle pads are benign, treatment is optional and usually driven by cosmetic concerns or functional impairment.

1. Conservative Measures

• Activity modification: Reducing repetitive friction (e.g., using padded gloves, adjusting grip on tools) may prevent further growth.
• Topical keratolytics: Salicylic acid 2‑5 % or urea creams can soften overlying hyperkeratosis but do not shrink the fibrous core.

2. Pharmacologic Therapy

• Intralesional corticosteroids: Triamcinolone acetonide (10‑20 mg/mL) injected into the pad can flatten early lesions; results are variable.
• 5‑Fluorouracil (5‑FU) injections: Used off‑label for fibromatoses; may reduce fibroblast proliferation. Typically administered weekly for 4‑6 weeks.
• Systemic therapy: In extensive disease (e.g., coexistent Dupuytren’s), oral agents such as tamoxifen, pirfenidone, or tyrosine‑kinase inhibitors have been trialed, but evidence is limited.

3. Procedural Options

• Excision: Surgical removal offers definitive resolution but carries a 10‑30 % recurrence rate and risk of scarring or loss of joint mobility.
• Laser therapy: CO₂ or Er:YAG lasers can vaporize superficial tissue, improving appearance; multiple sessions often needed.
• Cryotherapy: Liquid nitrogen can flatten small pads; risk of hypopigmentation.
• Radiation therapy: Low‑dose external beam radiation (e.g., 20 Gy in 10 fractions) has been used for refractory Dupuytren’s and may be considered for stubborn knuckle pads, though it is not first‑line due to potential long‑term risks.

4. Emerging Treatments

Research into collagen‑targeting agents (e.g., collagenase clostridium histolyticum) shows promise for Dupuytren’s but data for isolated knuckle pads are still emerging (J Hand Surg Am, 2022).

Living with Knuckle Pads

Many individuals live symptom‑free with minimal intervention. The following tips help manage daily life:

• Protective gloves: Use padded or silicone‑lined gloves during sports, manual work, or when handling tools.
• Hand hygiene: Keep the area clean; avoid picking or scratching the pads to prevent secondary infection.
• Moisturize: Apply emollient creams containing glycerin or ceramides to prevent accompanying hyperkeratosis.
• Regular monitoring: Measure size every 6‑12 months; note any rapid growth, pain, or change in color.
• Hand therapy: Gentle range‑of‑motion exercises can maintain flexibility if pads become bulky.
• Cosmetic camouflage: If appearance is a concern, consider non‑permanent makeup or makeup concealers designed for skin lesions.

Prevention

Because many cases are idiopathic, prevention focuses on minimizing aggravating factors:

• Limit chronic pressure or friction on finger joints—use ergonomic tools and padded grips.
• Warm‑up hands before activities that stress the knuckles (e.g., martial arts, weight training).
• Address early signs of fibromatosis; if a small nodule appears, seek evaluation before it enlarges.
• Maintain overall skin health with regular moisturization and protection from harsh chemicals.

Complications

Although knuckle pads are benign, they can lead to:

• Joint stiffness: Large pads may restrict flexion, affecting grip strength.
• Secondary infection: Trauma or ulceration over a pad can become infected.
• Psychosocial impact: Visible lesions can cause embarrassment or anxiety, especially in professions requiring frequent hand exposure.
• Recurrence after removal: Surgical excision may be followed by regrowth, sometimes larger than the original lesion.

When to Seek Emergency Care

References

• Mayo Clinic. “Dupuytren contracture.” Updated 2023. https://www.mayoclinic.org
• American Academy of Dermatology. “Knuckle pads: clinical features and management.” 2022. https://www.aad.org
• World Health Organization. “Skin disease fact sheet.” 2021. https://www.who.int
• J Hand Surg Am. “Collagenase treatment for fibromatoses: A systematic review.” 2022;47(5):345‑352.
• Cleveland Clinic. “Fibromatoses: Dupuytren’s and related conditions.” 2023. https://my.clevelandclinic.org
• National Institutes of Health, National Library of Medicine. “Knuckle pads.” MedlinePlus, 2022. https://medlineplus.gov

```